News articles about RTI Surgical (NASDAQ:RTIX) have trended somewhat positive on Wednesday, Accern reports. The research group ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. RTI Surgical earned a coverage optimism score of 0.02 on Accern’s scale. Accern also gave media stories about the medical equipment provider an impact score of 46.1220857831323 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
A number of equities analysts have weighed in on RTIX shares. BidaskClub upgraded shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Wednesday, February 21st. Zacks Investment Research lowered shares of RTI Surgical from a “hold” rating to a “sell” rating in a research report on Tuesday, March 6th. Finally, Craig Hallum upgraded shares of RTI Surgical from a “hold” rating to a “buy” rating in a research report on Friday, March 2nd. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and one has given a buy rating to the stock. The stock currently has a consensus rating of “Hold”.
RTIX stock traded up $0.12 on Wednesday, hitting $4.88. 25,695 shares of the company’s stock were exchanged, compared to its average volume of 148,354. The company has a market capitalization of $301.24, a price-to-earnings ratio of 80.00, a P/E/G ratio of 2.67 and a beta of 1.69. RTI Surgical has a fifty-two week low of $3.58 and a fifty-two week high of $6.00. The company has a current ratio of 3.50, a quick ratio of 1.39 and a debt-to-equity ratio of 0.23.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.